Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England

Copland, Emma and Patone, Martina and Saatci, Defne and Handunnetthi, Lahiru and Hirst, Jennifer and Hunt, David P. J. and Mills, Nicholas L. and Moss, Paul and Sheikh, Aziz and Coupland, Carol A. C. and Harnden, Anthony and Robertson, Chris and Hippisley-Cox, Julia (2024) Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. Nature Communications, 15 (1). 5723. ISSN 2041-1723 (https://doi.org/10.1038/s41467-024-50151-0)

[thumbnail of Copland-etal-NC-2024-Author-correction-Safety-outcomes-following-COVID-19-vaccination]
Preview
 Text. Filename: Copland-etal-NC-2024-Author-correction-Safety-outcomes-following-COVID-19-vaccination.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (369kB)| Preview

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-47745-z, published online 27 May 2024 The original version of this article contained information on vaccine dose amount (full or half) in Table 2 and Supplementary Table 1. This has subsequently been found to be inaccurate due to inconsistent coding in the raw data. The vaccine dose amount has therefore been removed from Table 2 and Supplementary Table 1. This data was not used elsewhere in the analysis. An additional line has been added to the introduction to summarise vaccine doses that were given to the population: “Those aged 12 years and above were given a full dose of BNT162b2 vaccine (30 micrograms), and children aged 5–11 years were given a dose of 10 micrograms of BNT162b2 vaccine.” These changes have been made in the PDF and HTML versions of the article.

CORE (COnnecting REpositories)